FULL EVENT GUIDE

Download the Multi-Omics Based Drug Discovery & Development Summit 2025 Full Event Guide

The Multi-Omics Summit will unite a diverse range of biopharma leaders and academic KOLS, including Johnson & Johnson, Sonoma Biotherapeutics, Amgen, Resilient Biotics, Gilead, and more, seeking to effectively apply multi-omics to accelerate target discovery, therapeutic development, and clinical progression.

Official Brochure

What To Expect

Having Trouble Downloading the Brochure?
Let us know and we'll email it to you instead!

Multi-Omics Based Drug Discovery & Development Transform multi-omics data integration and analysis to generate comprehensive insights, with interactive discussion sessions
Multi-Omics Based Drug Discovery & Development Realize the full potential of multi-omics analysis to optimize therapeutic development, with case study presentations from biopharma leaders
Multi-Omics Based Drug Discovery & Development Achieve efficient multi-omics workflows across project teams by learning from industry leaders successfully implementing multi-omics

 

Sneak Peek at Our Speaker Faculty
Andrew Parton, Multiomic Health

Andrew Parton

Associate Director - Data Science

MultiOmic Health

Elsa Molina, Salk IKnstitute

Elsa Molina

Director, Single-Cell & Spatial Omics Core

Salk Institute of Biological Studies

James Yurkovich, Phenome Health

James Yurkovich

Chief Technology Officer

Phenome Health

Priyank Patel, Boehringer Ingelheim

Priyank Patel

Principal Scientist

Boehringer Ingelheim

Si Wu, Amgen

Si Wu

Senior Principal Scientist

Amgen